Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
In 2011, it was estimated that 8.3% of Americans--25.8 million children and adults in all--have diabetes. A great number of them use insulin to regulate their condition, through either syringes or insulin pumps because insulin is a peptide hormone which breaks up when swallowed. But a new holy grail for insulin patients is on the way: a swallowable insulin pill. Two biopharma companies--a large multinational and a small Israeli firm--are racing to create the first insulin pills; it is likely that within 15 years, diabetics will be able to get rid of their needles entirely.
Nadav Kidron is excited about his product's progress. The Israeli pharmaceutical executive heads up Oramed, which received a patent in the European Union less than two weeks ago for oral ingestion of insulin. ?We want to make sure oral insulin isn't a last resort,? Kidron told Fast Company in a telephone interview. ?We want to complement the body's insulin output and make it a primary solution alongside exercise and not a last resort like injection. Billions of dollars are spent each year on diabetes, and we cannot spend that much as a society. There is no other choice.?
http://www.fastcompany.com/3022282/a-diabetic-seismic-shift-the-race-for-insulin-pills
Nadav Kidron is excited about his product's progress. The Israeli pharmaceutical executive heads up Oramed, which received a patent in the European Union less than two weeks ago for oral ingestion of insulin. ?We want to make sure oral insulin isn't a last resort,? Kidron told Fast Company in a telephone interview. ?We want to complement the body's insulin output and make it a primary solution alongside exercise and not a last resort like injection. Billions of dollars are spent each year on diabetes, and we cannot spend that much as a society. There is no other choice.?
http://www.fastcompany.com/3022282/a-diabetic-seismic-shift-the-race-for-insulin-pills